|Mr. Randy Maslow||Co-Founder, Pres, MD, Interim CEO & Director||600k||N/A||1956|
|Mr. Julius John Kalcevich||CFO & Corp. Sec.||450k||N/A||1974|
|Mr. Robert R. Galvin||Sr. VP, Chief Admin. Officer & Interim COO||N/A||N/A||1961|
|Ms. Megan W. Kulick CFA||VP of Investor Relations||N/A||N/A||N/A|
|Dr. Richard J. Boxer||Chief Medical Officer||N/A||N/A||N/A|
|Mr. Michael R. Woolston||Sr. VP of Manufacturing, Supply Chain & Quality||N/A||N/A||N/A|
iAnthus Capital Holdings, Inc. develops, owns, and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. Its products include smokable flower and pre-rolls; concentrates, such as vaporizer cartridges, wax products, tinctures, topicals, etc.; cannabis infused edibles; and various cannabidiol (CBD) products. The company also distributes and retails CBD products to dispensaries and retail stores, as well as online. As of July 31, 2020, it operated 36 dispensaries in 11 states. The company is based in Vancouver, Canada.
iAnthus Capital Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.